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http://dx.doi.org/10.1016/j.jprot.2013.10.004A B S T R A C TAvailable online 11 October 2013 Clostridial collagenases are among the most efficient degraders of collagen. Most clostridia
are saprophytes and secrete proteases to utilize proteins in their environment as carbon
sources; during anaerobic infections, collagenases play a crucial role in host colonization.
Several medical and biotechnological applications have emerged utilizing their high
collagenolytic efficiency. However, the contribution of the functionally most important
peptidase domain to substrate specificity remains unresolved. We investigated the active
site sequence specificity of the peptidase domains of collagenase G and H from Clostridium
histolyticum and collagenase T from Clostridium tetani. Both prime and non-prime cleavage
site specificity were simultaneously profiled using Proteomic Identification of protease
Cleavage Sites (PICS), a mass spectrometry-based method utilizing database searchable
proteome-derived peptide libraries. For each enzyme we identified >100 unique-cleaved
peptides, resulting in robust cleavage logos revealing collagen-like specificity patterns: a
strong preference for glycine in P3 and P1′, proline at P2 and P2′, and a slightly looser
specificity at P1, which in collagen is typically occupied by hydroxyproline. This specificity
for the classic collagenmotifs Gly-Pro-X and Gly-X-Hyp represents a remarkable adaptation
considering the complex requirements for substrate unfolding and presentation that need
to be fulfilled before a single collagen strand becomes accessible for cleavage.
Biological significance
We demonstrate the striking sequence specificity of a family of clostridial collagenases
using proteome derived peptide libraries and PICS, Proteomic Identification of protease
Cleavage Sites. In combination with the previously published crystal structures of these
proteases, our results represent an important piece of the puzzle in understanding the
complex mechanism underlying collagen hydrolysis, and pave the way for the rational
design of specific test substrates and selective inhibitors.Keywords:
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Collagens are by far the most abundant proteins in mammals
that constitute up to 90% of the extracellular matrix of a tissue,
thus imparting its structural integrity. Collagen is an astonishing
molecule of remarkable primary, secondary, tertiary and
quaternary structure, fascinating scientists for decades [1–4].
Interstitial collagen is built up by three polypeptide strands with
high proline and hydroxyproline (Hyp) content (combined
occurrence >20%) and a glycine at every third position. Pro-
Hyp-Gly thus forms themost common triplet (10.5%). Each strand
possesses the conformation of a left-handed polyproline II helix,
twisted together into a rigid, rod shaped, right-handed super
helix of approximately 300 nm in length and 1.5 nm in diameter,
burying the peptide bonds within the interior of the helix. The
three alpha-chains are held together by numerous inter-chain
hydrogen bonds, and highly ordered hydration networks
surround the triple helices. Collagen molecules spontaneously
self-assemble into larger quaternary assemblies of great tensile
strength, first as fibrils and then as bundles of fibrils to fibers
up to 2 μm in length and 300 nm in diameter. Additional
intermolecular interactions increase collagen thermal stability
and afford its great tensile strength and long half-life of 15 years
for skin collagen and of over 100 years for cartilage collagen [5–9].
Equally fascinating as collagen is the repertoire of proteases,
often termed collagenases, capable of degrading native triple
helical collagen. Human proteases such as the zinc-dependent
matrix metalloproteinases (MMP) 1, 8, 13 and 14, and the
cysteine protease cathepsin K, play crucial roles in the dynamic
remodeling of connective tissue under physiological and/or
pathological conditions [10,11]. Notably, all enzymes show
distinct preferences towards the different fibrillar collagen
substrates and cleave only at well-defined sites; e.g. MMP1,
MMP8, MMP13 andMMP14 all share the unique ability to cut the
native super-helix into 3/4 and 1/4 length fragments at a single
peptide bond (775–776) between a glycine residue at P1 and a
leucine (on type I collagen α2) or isoleucine (on type I collagen
α1) at P1′. However, their distinct preferences for different types
of interstitial collagens indicate different functional roles in the
human body [12]. Notably, the hemopexin carboxyl-domain
exosites bind collagen and are essential for cleavage [13–16].
Exosites represent specialized substrate binding sites located
on domains outside the active site cleft, providing substrate
interactions not influenced by the primary specificity pockets,
thus refining substrate affinity and proteinase specificity [11].
For cathepsin K, five distinct cleavage sites have been identified
within type I collagen, and one in type II collagen. In all cases,
subsequent collagenolysis is performed by gelatinases (MMP2,
MMP9) and other synergistic proteinases only after the initial
dismantling of the collagen triple helix that exposes more
generally susceptible proteolytic sites upon denaturation
[10,17,18]. However, MMP2 also has a weak native collagenase
activity imparted by its three fibronectin type II repeats [15]
which function as exosites to localize the enzyme on the
substrate.Bacterial collagenases are secreted by saprophytic clostridia
to utilize collagenas a carbon source. Pathogenic strains suchas
Clostridium histolyticum and Clostridium tetani use these enzymes
to facilitate host invasion, colonization and toxin diffusion
during anaerobic infections [19,20]. In contrast to the tightly
regulated natural turnover of collagen in the host organism,
clostridial collagenases circumvent all constraints for collagen
degradation and are capable of efficiently digesting most, if not
all, types of collagen [21–23]. Their enzymatic activity is
independent of the quaternary collagen assembly, which is
especially remarkable given collagen's triple helical structure
that renders it resistant to most other proteases [24–26].
Clostridial collagenases not only initiate hydrolysis by multiple
cleavages within the triple helical region, but also completely
degrade the obtained fragments into a mixture of small
oligopeptides [22,24,27]. This ability is often referred to as
broad substrate specificity of clostridial collagenases [21–23],
although no natural substrate other than collagen has been
reported to our knowledge. These properties place clostridial
collagenases among the most efficient enzymes degrading all
types of collagen, which is also exploited by a diverse spectrum
of medical and biotechnological applications. For instance,
collagenases from C. histolyticum are approved therapeutic
agents for breaking down the tough collagen cords in Morbus
Dupuytren [28,29] and are widely used in enzymatic wound
debridement [30,31] and tissue dissociation experiments [32,33].
Clostridial collagenases are large multi-modular zinc-
metalloproteinase of approximately 115 kDa, consisting of
four to six domains [19,26,34–36] (Fig. 1). As members of the
gluzincin superfamily of metalloproteinases they share the
common HExxH zinc binding motif within the peptidase
domain of the N-terminal collagenase unit, complemented by
an additional zinc-coordinating glutamate 28 to 30 amino acid
downstream. Two to four accessory domains of approximately
10 kDa each form a C-terminal collagen recruitment unit of
variable composition (Fig. 1), providing important exosites for
native collagenolysis, responsible for collagen binding [37] and
swelling [38] (Fig. 1). Although most clostridial strains possess
only one collagenase, C. histolyticum encodes for two with
complementary characteristics: collagenase G (ColG) exhibits
high collagenolytic and low peptidolytic activity, whereas its
homologue collagenase H (ColH) shows low collagenolytic and
high peptidolytic activity [39].
Recently,we establisheda flexible expressionandpurification
platform for clostridial collagenases [35], undertook a ‘one
substrate, one inhibitor’-based biochemical characterization of
the collagenase units of ColG, ColH and the C. tetani collagenase
(ColT) [40], and reported the crystal structures of the ColG
collagenase unit [36], the ColG Polycystic Kidney Disease
(PKD)-like domains [37], and of the ColH and ColT peptidase
domains [41]. TheColG crystal structure showeda saddle-shaped
architecture of the N-terminal collagenase unit (Tyr119-Gly790)
capable of degrading native triple-helical collagen even in the
absence of its accessory collagen recruitment domain [36]. The
N-terminal activator domain (Tyr119-Asp388) was required for
Fig. 1 – Schematic representation of the domain organization of Clostridium histolyticum collagenases G (ColG) and H (ColH), and
collagenase T from C. tetani (ColT). The location of the catalytic zinc ion is indicated within the peptidase domain. PKD,
polycystic kidney disease-like domain; CBD, collagen binding domain.
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activity. The crystal structures of the peptidase domains of ColH
andColT revealed a calciumbinding site in close proximity to the
active site, an aspartate switch for zinc stabilization and a
conformational selectivity filter [41]. The calcium close to the
active site explained for the first time its importance for
structural integrity and enzymatic activity and the aspartate
switch stabilized the active site zinc analogous to the tyrosine
switch in active astacin [42]. The selectivity filter regulated the
substrate access to the active site by steric shielding, explaining
their opposing peptidolytic and collagenolytic efficiency [41].
The dynamic interactions between proteases and substrates
are also reflected in the cleavage site specificity, which relies
largely on the recognition of the amino acid sequences flanking
the scissile peptide bond by the protease active site. In 1967,
Schechter and Berger introduced the standard nomenclature
for describing interactions between a peptide substrate and the
active site of a protease [43]. Residues N-terminal to the scissile
peptide bond are designated as the non-prime (P) side, and
residues C-terminal as prime (P′) side, both interacting with
complementary substrate recognition sites in the protease
active site cleft, termed S and S′, respectively. Protease
specificity can be profiled using a variety of approaches [44].
Uniquely among these, Proteomic Identification of protease
Cleavage Sites (PICS) determines both the full prime and
non-prime cleavage site preferences in a single experiment
and in a high throughput manner [45]. PICS uses proteome-
derived peptide libraries, generated by digestion of a suitable
proteome with a highly specific protease e.g. trypsin and GluC.
For cleavage specificity analysis, primary amines in the
substrate library are blocked prior to incubation with the
test protease of interest. The blocking step is critical as it allows
for selective biotin labeling of the newly generated neo-
N-termini. This enables selective streptavidin capture and
mass spectrometry-based identification of the prime side
cleavage products. Due to the non-random sequence of the
proteome-derived test substrates, the complete cleavage site
can be reconstructed by bioinformatics of the non-prime sidesequences from proteome databases. Alignment of dozens to
hundreds of cleaved peptides then provides a detailed profile of
the test protease cleavage site specificity.
Here, we present the cloning, expression and purification
of the peptidase domain of ColG, and the first detailed active
site specificity profiles of the peptidase domains of three
different pathogenic clostridial collagenases, C. histolyticum
ColG, ColH and C. tetani ColT. Our results showed a striking
match to the cleaved sequence in collagen, demonstrating
that the exquisite specificity of clostridial collagenases for
collagen arises primarily from the active site, and does not
depend on exosite contributions from the ancillary domains.
This sheds additional light on the complex mechanism of
hydrolyzing large quaternary protein molecules such as
collagen and provides new opportunities for the design of
sensitive assays and specific peptidic inhibitors.2. Material and methods
2.1. Materials
All restriction enzymes were purchased from Fermentas
(St. Leon-Rot, Germany); primers were obtained from Sigma-
Aldrich (Vienna, Austria), and sequence analysis was performed
at EurofinsMWGOperon (Ebersberg, Germany). All reagentswere
of the highest standard available from AppliChem (Darmstadt,
Germany) or Sigma-Aldrich (St. Louis, MO, USA), unless stated
otherwise.
2.2. Cloning
Based on the crystal structure of the collagenase unit of
collagenase G from C. histolyticum (pdb entries 2y3u) [36], we
designed a peptidase domain construct comprising the amino
acid sequence Asp398 to Gly790 (numbering according to
Swiss-Prot entry Q9X721). After PCR amplification from the
full length construct [35], the peptidase domain was cloned
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His6-tag followed by a TEV-protease recognition site
(ENLYFQxGGT), and the peptidase starting sequence. Primers
used were: ColG-fwd: 5′-ACGTggtacc GATCACGATAAGTTC
TTAGA-3′ and ColG-rev: 5′-ACGTggatccTTACCCATTATCTG
TTAAAACCC-3′; restriction sites encoding for Kpn I and Bam
HI are represented in lowercase letters. PCR products were
purified with MinElute PCR Purification Kit (Qiagen, Germany)
and digestedwith the appropriate restriction enzymes, ligated
overnight under standard conditions, and transformed into
XL2-Blue (Stratagene, Germany) cells via electroporation.
Nucleotide sequence was confirmed by DNA sequencing
prior to protein expression (Eurofins MWG Operon, Ebersberg,
Germany). Cloning of the peptidase domain constructs of
collagenase H from C. histolyticum (Leu331-Gly721; Swiss-Prot
entry Q46085) and collagenase T from C. tetani (D340-K731;
numbering according to Swiss-Prot entry Q899Y1) has been
described previously [41].
2.3. Expression and purification
After induction with 1 mM IPTG at OD600 0.8, the peptidase
domain construct of ColG was expressed in soluble form in
Escherichia coli BL21(DE3) cells for 4 h at 37 °C in 2 L baffled
flasks, containing 500 mL LB-medium with 100 μg/mL
ampicillin. Cells were collected by centrifugation (4000 g,
10 min, 4 °C) and resuspended in 1/100 culture volume of
Buffer A (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole,
pH 8.0). Cells were lysed by sonication (4 cycles of 45 s, at 45W
power, and with 0.5 s intervals), and clarified by two cycles of
centrifugation (15,000 g, 10 min, 4 °C). To reduce viscosity, we
enzymatically removed DNA from the sample with 1.0 μg/mL
DNase I and 5.0 mMMgCl2 and incubation for 15 min on ice. All
subsequent purification steps were carried out at 4 °C. The
three-step purification scheme included immobilized metal
affinity chromatography via pre-equilibrated Ni–NTA resin
(Qiagen), His tag removal by in-house prepared TEV protease
in amolar ratio of 1:100 overnight, re-chromatography, and size
exclusion chromatography Superdex 75 10/300 GL, Amersham
Bioscience for re-buffering (10 mM Tris, 10 mM NaCl, pH 7.5)
and as final polishing step, as described elsewhere in great
detail for other clostridial collagenase constructs [35,36,40].
Protein samples were concentrated before and after size ex-
clusion chromatography to a concentration of approximately
10 mg/mL using washed and pre-equilibrated 10 kDamolecular-
weight cutoff Centricons (Amicon-Ultra, Millipore). Protein
concentration was assayed by UV280, using the molar ex-
tinction coefficient of 77,700 M−1 cm−1, calculated by the
ExPASy ProtParam tool [46]. After purification, samples were
snap-frozen in liquid nitrogen and stored as 25 μl aliquots at
−80 °C until use. Expression and purification of the peptidase
domains of ColH and ColT has been described previously [41].
2.4. Enzymatic assay
Enzymatic assays with N-[3-(2-Furylacryloyl)]-L-leucyl-glycyl-
L-prolyl-L-alanine (FALGPA) as substrate were performed as
described by van Wart and Steinbrink [47] and detailed in
the manufacture's protocol (AppliChem, Germany). A 1.0 mM
stock solution was prepared in reaction buffer, and theconcentration verified in solution via UV absorbance at
305 nm (ε305 = 24.70 mM−1 cm−1). All measurements were
carried out at 25 °C, and the decrease in absorbance upon
substrate cleavage was monitored at 345 nm, as described in
detail [40].
2.5. PICS peptide library preparation
Human whole proteome-derived peptide libraries were
essentially prepared as described in detail previously [48]. In
brief, cell pellets collected from HEK293 cell cultures were lysed
in 20 mM Hepes, pH 7.5, supplemented with 0.1% sodium
dodecyl sulfate (SDS) and protease inhibitors (1× Roche
complete protease inhibitor cocktail, supplemented with
1 mM PMSF and 10 mM EDTA), and centrifuged to remove cell
debris (26,000 g, 1 h, 4 °C). Proteins in the supernatant were
denaturedwith 4 M guanidine hydrochloride, and reducedwith
DTT (5 mM, 1 h, 37 °C). Free sulfhydryl groups were alkylated
with iodoacetamide (20 mM, 3 h, 20 °C, in the dark). Labeling
was stopped by adding further DTT (5 mM, 15 min, 20 °C)
and the reaction was cleaned-up by chloroform/methanol
precipitation [21]. The protein pellet was air-dried, resuspended
in 50 μl of 0.1 M NaOH and diluted with ddH2O to an estimated
protein concentration of 2 mg/mL. Samples were neutralized
with 100 mM Hepes, 5 mM CaCl2, pH 7.2, and digested
overnight at 37 °C with trypsin (TPCK-treated trypsin, Sigma)
at a protease-to-protein weight ratio of 1:100. After inactivation
of trypsin with 1 mM PMSF (30 min, 20 °C), undigested protein
aggregates were removed by centrifugation (20,000 g, 10 min,
4 °C). Reduction and alkylation stepswere repeated (5 mMDTT,
1 h, 37 °C; 40 mM iodoacetamide, 1.5 h, 20 °C, in the dark) to
ensure complete protection of free sulfhydryl groups. Primary
amines were protected by reductive dimethylation with
formaldehyde (30 mM) and sodium cyanoborohydride (15 mM)
for 16 h overnight at 20 °C. To ensure completeness of amine
labeling, another 15 mM formaldehyde and 15 mM sodium
cyanoborohydride were added and reaction was incubated for
additional 2 h at 37 °C. The resulting peptides were desalted by
size exclusion chromatography (Sephadex G-10 columns,
10 mM potassium phosphate buffer, pH 2.7, 10% methanol)
and, after vacuum evaporation of methanol, further purified
by reversed-phase chromatography (RESOURCE RPC column,
GE Healthcare) using an FPLC system (Äkta Explorer, GE
Healthcare). Eluates were concentrated to a minute amount of
solvent by vacuum concentration, and resuspended in water to
an approximate concentration of 2.0 mg/mL. Peptide con-
centration was estimated using the bicinchoninic assay (BCA,
Pierce). Purified tryptic human whole proteome peptide
libraries were stored in aliquots of 200 μg at −80 °C until use.
2.6. PICS cleavage site specificity assay
Cleavage assays were performed by incubating 250 μg of human
whole-proteome peptide library with active recombinant
clostridial collagenase at a protease to peptide library ratio of
1:50 (w/w) in 50 mMHepes, 150 mMNaCl, 5 mMCaCl2 at pH 7.4,
incubated for 16 h overnight, and stopped by heat inactivation at
70 °C for 30 min. Prime-side cleavage products were isolated by
positive enrichment essentially as described [48]. In brief,
cleaved peptides presenting neo-amino termini generated by
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sulfosuccinimidyl 2-(biotinamido)-ethyl-1,3-dithiopropionate
(amine-reactive biotin with a cleavable disulfide linker;
Pierce) for 2 h at ambient temperature. Biotinylated prime-side
cleavage products were separated from uncleaved peptides
by incubation with 300 μL Streptavidin Sepharose slurry
(GE Healthcare) for 2 h at ambient temperature with mild
agitation. After extensive washing with 50 mM Hepes, pH 7.2,
biotinylated peptides were eluted with 20 mM DTT (2 h, 20 °C),
desalted using reversed-phase solid phase extraction (Sep-Pak,
Waters) with binding and washing in 0.1% (vol/vol) formic acid
and elution in 80% (vol/vol) acetonitrile. The eluates were
evaporated tonear dryness in a SpeedVac concentrator, brought
to 15 μl with 0.1% formic acid, and stored at −20 °C until LC–MS/
MS analysis.
2.7. Nanoflow HPLC–MS/MS analysis and spectrum to
sequence assignment
LC–MS/MS analysis was performed on a nano-LC system
(Thermo) coupled to a linear ion trap-orbitrap (LTQ-Orbitrap
XL, Thermo Finnigan, San Jose, CA) using a nanospray
ionization source, a 2-cm-long, 100-μm-inner diameter fused
silica trap column, a 20 cm long, 50-μm-inner diameter fused
silica fritted analytical column, and a 20-μm-inner diameter
fused silica gold coated spray tip (6-μm-diameter opening,
pulled on a P-2000 laser puller from Sutter Instruments, coated
on Leica EM SCD005 Super Cool Sputtering Device). The trap
column was packed with 5 μm-diameter Aqua C-18 beads
(Phenomenex), while the analytical column was packed with
3 μm-diameter Reprosil-Pur C-18-AQ beads (Dr. Maisch,
Ammerbuch, Germany). Buffer A consisted of 0.5% acetic acid,
and buffer B of 0.5% acetic acid and 80% acetonitrile. Gradients
were run from 0% B to 15% B over 15 min, then from 15% B to
40% B in the next 65 min, then increased to 100% B over 10 min
period, and held at 100% B for 30 min. Sample pick up was at
10 μL/min, sample loading volumewas 20 μL (for 5 μL samples),
pre-column equilibration volume 20 μL and analytical column
equilibration volume 4 μL. The LTQ-Orbitrap was set to acquire
a full-range scan at 60,000 resolution from 350 to 1800 m/z in
the Orbitrap, and to simultaneously fragment the top five
peptide ions in each cycle in the LTQ (minimum intensity 200
counts). Parent ions were then excluded from MS/MS for the
next 180 s. Single charged ionswere excluded since in ESImode
peptides usually carry multiple charges. The Orbitrap was
continuously recalibrated using the lock-mass function [49].
Error of massmeasurement was usually within 5 ppm and was
not allowed to exceed 10 ppm (see Supplementary Fig. 1).
2.8. Data analysis
Acquired Orbitrap data were centroided and converted to the
mzXML and mgf format using ms-convert [50]. Peptides were
identified from the human UniProt database (version 2012–11)
using the search engines X! TANDEM [51] and Mascot [52].
Peptides were analyzed with PeptideProphet [53] and iProphet
[54], both implemented within the Trans Proteomic Pipeline
v4.6 [55]. Peptides were analyzed at a false discovery rate of 1%
for each peptide by using a decoy search strategy. Search
parameters included a mass tolerance of 10 ppm for parentalions and 0.5 Da for fragment ions, allowing up to three
missed cleavages, and for the following peptide modifications:
Carbamidomethylation of cysteine residues (+57.02 Da),
dimethylation of lysine amines (+28.03 Da), variable
methionine oxidation (+15.99 Da), and thioacylation (+88.00 Da)
anddimethylation (+28.03 Da) of peptideN-termini.N-terminally
thioacylated peptides identified by MS/MS represent prime-side
cleavage products of the proteases of interest. The complete
cleavage sites were reconstructed by bioinformatic deter-
mination of the non-prime-side sequences from the databases
using WebPICS [56], available at http://clipserve.clip.ubc.ca/pics/.
WebPICS generates a non-redundant list of identified prime side
peptide sequences, matches these to the human UniProt protein
database, and extracts the non-prime cleavage side sequence to
the next cleavage site of the enzyme used for library generation,
i.e. to the next N-terminal Arg or Lys for a trypsin-generated
library. Subsite positions with ambiguous information coming
from different protein isoforms are omitted and replaced by
X, the one-letter notation for an unknown amino acid, for
further analysis. Reconstructed cleavage sites were aligned and
summarized as iceLogos [57].
2.9. In-silico structural analysis
Based on the crystal structures of collagenase G (pdb entries
4are [41] and 2y6i [36]) and humanmatrix metalloproteinase 1
(hMMP1; pdb entry 1hfc [58]) we performed peptide docking
with the respective ideal substrates using the Rosetta
FlexPepDock web server [59,60], allowing full flexibility to the
peptide and side-chain flexibility to the protease. The results
were optimized based on the available complex structures for
the prime site, and the anti-parallel edge strand for nonprime
substrate recognition. Molecular graphic figures were made
using the molecular visualization system PyMOL (The PyMOL
Molecular Graphics System, Version 1.5.03, Schrödinger, LLC)
[61].3. Results
3.1. Expression and purification of the peptidase domains
of collagenase G, H and T
Wecloned andpurified thepeptidase domainof ColG, spanning
amino acids Asp398-Gly790 (Fig. 1A), based on the published
crystal structures of the collagenase unit of ColG (pdb entries
2y3u, 2y50, 2y6i, and 4are) and the peptidase domains of ColH
(pdb entries 4ar1, 4arf) and ColT (pdb entries 4ar8, 4ar9).
Expression typically yielded 25 mg of highly pure and
monodisperse protein after a 3-step purification scheme (from
1 L of cell culture). The purified recombinant protein migrated
on a denaturing, non-reducing SDS-PAGE gel with an apparent
molecular mass of 40 kDa, and was found to be at least 95%
homogeneous (Fig. 2A). Dynamic light scattering analysis
proved the protein to be highly monodisperse and suitable for
downstream applications such as protease specificity profiling
or crystallization (Supplementary Fig. 2). Although the obtained
crystalswere of insufficient quality for structure determination,
they demonstrate the high quality and purity of the protein
preparation. A 3D model based on the structure of the ColG
Fig. 2 – (A) SDS-PAGE monitoring of the expression and purification of the peptidase domain of ColG. M: PageRuler Prestained
Protein Ladder (Fermentas); lane 1: BL21 DE3 cells before induction with 1 mM IPTG; lane 2: clarified lysate; lane 3: sample
before immobilizedmetal ion affinity chromatography (IMAC) purification; lane 4: IMAC flow-through; lane 5: IMACwash; lane
6: IMAC elution; lane 7: sample after His-tag removal; lane 8: flow-through of IMAC re-chromatography; lane 9: wash of
re-chromatography; lane 10: elution of re-chromatography; lanes 11 to 14: sample after size exclusion chromatography.
(B) SDS-PAGE analysis of the peptidase domains of ColG (lane 1), ColH (lane 2), and ColT (lane 3) used for protease specificity
profiling. M: BLUeye Prestained Protein Ladder (GeneDireX). (C) Ribbon representation of the ColG peptidase domain based on
the crystal structure of its collagenase unit and the crystal structure of the peptidase domain of ColT. (D) View towards the
active side. Zinc binding ligands are shown in dark red, zinc and calcium are shown as yellow and red spheres, respectively.
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domain (pdb entry 4ar9) is shown in Figs. 2C and 2D to illustrate
the overall shape and active site geometry of the target protein.
Enzymatic activity was verified with the standard substrate for
clostridial collagenases, N-[3-(2-Furyl)acryloyl]-Leu-Gly-Pro-Ala
(FALGPA), and was in the same range as for the collagenase
module of ColG (data not shown). The protein batches of the
peptidase domains of ColH and ColT were of similar or even
superior quality, and were previously used to determine their
crystal structures [41].
3.2. Specificity profiling by Proteomic Identification of
protease Cleavage Sites (PICS)
In a first step, we generated a PICS peptide library by digesting
human cell lysates. This peptide library contained oligopeptides
representing the biological amino acid diversity, with the
constraint of Lys and Cys being modified by dimethylation and
carbamidomethylation during library preparation, respectively.
Purified recombinant peptidase domains of ColG, ColH and ColT
were incubated with aliquots of the tryptic peptide library,
prime-side cleavage products enriched by biotin-mediated
affinity purification and identified by high-resolution massspectrometry. Following spectrum-to sequence assignment at a
false discovery rate (FDR) of 1% and bioinformatic inference of
the non-prime side sequences from the proteome database
(Supplemental Tables S1, S2, and S3; Supplementary Fig. 1) we
obtained 108, 153, and 183 unique cleaved P5 to P5′ sequences for
ColG, ColH and ColT, respectively. For each protease, the cleaved
peptide sequenceswere aligned at the cleavage site, occurrences
of each amino acid at each position counted and summarized
as heat map (Fig. 3, left panels). Normalization to the natural
amino acid abundance in human protein database revealed the
subsite preferences (Fig. 3, middle panels). The over- and under-
representation of each amino acid was further analyzed by
iceLogos [57], which additionally tested the significance of the
observed changes from natural amino acid occurrence while
accounting for sample size (Fig. 3, right panels). It should be
noted that, due to the substrate specificity of trypsin, the
employed library lacked peptides with internal Arg and Lys.
However, since clostridial collagenases were previously shown
not to prefer Arg/Lys in subsites S1′ and S2′ [62], we anticipate
that our results accurately represent the overall sequence
specificity. The number of interacting sites depends on the
unique structure of the active site, but usually extends up to four
or five amino acids in each direction.
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parable active site specificities, perfectly matching the
repetitive amino acid sequence of collagen thus highlighting
their collagenolytic nature (Fig. 3). Distinct preferences at
positions P3 to P4′ were revealed, with common strong
preferences for Gly in P3 and P1′ and for Pro in P2 and P2′,
reminiscent of the typical collagen motif Gly-Pro-X. In
addition, Pro was more than 4-fold enriched in P1, and at
least 2.4-fold in P3′, indicating the capability to also
accommodate the second most prominent collagen sequence
pattern, Gly-X-Hyp. In line with these observations, P1′ was
occupied by Gly in 57%, 68%, and 57% of all sequences cleaved
by ColG, ColH, and Colt, respectively, with Ala accounting for
additional 26%, 19%, and 26% at this position. In P2′, Pro was
by far the most dominant amino acid, with 6 to 11 fold
enrichment over its natural abundance. Besides Pro, large
hydrophobic residues such as Phe, Trp, and Met, or large
slightly polar ones such as Tyr and Gln, were moderately
preferred in P1. In contrast, small polar residues like Ser or Thr
as well as negatively charged residues were significantly
underrepresented relative to their natural abundance at
nearly every position throughout the specificity profiles.
Next, we investigated cooperative effects between Pro and
the occurrence of other amino acids in subsites close to the
cleavage sites. When only substrate peptides with Pro in P1
were considered, 60% of those identified for ColH and over
86% of the ColG and ColT cleavage sites showed Gly in P3, and
more than 80% showed either Gly or Ala in P1′. In the case of
ColH, 90% of the cleavage sites had Gly in P1′, whereas ColT
allowed His/Met/Ser (19%) and Ala (27%) although Gly was the
most favored (54%). The same picture held true when we
considered sites with Pro in P2; 89%, 97%, and 83% of the
identified substrate peptides for ColG, ColH, and ColT had Gly
or Ala in P1′, and 92%, 81%, and 88% in P3 for ColH, ColG and
ColT, respectively. Also 94%, 94%, 86% of the respective ColH,
ColG and ColT identified cleavage sites with Pro in P2′ showed
Gly or Ala in P1′. Remarkably, a reduced occurrence of Pro in
P1 was observed for ColG and ColH cleavage sites where Ala
was in P1′, while Pro increased in P2. In ColH this effect was
most pronounced: The Pro occurrence dropped to 3% in P1,
but increased to over 70% in P2. The opposite observation was
made in peptides with Gly in P1′; Pro was more strongly
enriched in P1 in all three cases. All the three obtained
specificity profiles show the perfect adaption of clostridial
proteases to collagen as their substrate. Stunningly, this
collagen-like active site specificity pattern was possible even
though none of the identified peptides originated from
collagen itself, as it was not present in the proteome used
for peptide library preparation.Fig. 3 – PICS specificity profiles for collagenase G, H, and T. Align
(A), 153 cleavage sites for ColH (B), and 183 cleavage sites for Col
occurrence (left panels) and the fold-change over the natural abu
showing percent difference compared to natural amino acid abu
(www.gnuplot.info). Single letter code for amino acid residues plo
the x axes. In iceLogos, significantly over-represented amino aci
below the axis, and amino acids that have not been identified ar
have been applied to all three proteases.3.3. Structural in-silico active site comparison of clostridial
collagenases and their human counterparts, the
matrix metalloproteinases
Up to now, 23members of the humanmatrixmetalloproteinase
(MMP) family, sharing significant sequence homology, have
been identified [63,64]. They are traditionally subdivided into:
(i) collagenases (MMP1, 8, 13, and 18), (ii) gelatinases (MMP2 and
9), (iii) stromelysins (MMP3, 10, and 11), matrilysins (MMP7, and
26), and (v)membrane-typeMMPs (MT-MMPs;MMP14, 15, 16, 17,
24, and 25), even though some of the MMPs (e.g.MMP12) do not
fit into any of these functional groups [64,65]. We chose MMP1,
also known as interstitial or fibroblast collagenase, for our
structural comparison, as it was considered as the prototype for
human collagenases [66–68].
First, we superimposed the active sites of collagenase G and
MMP1, to provide an impression of their similarities and
differences (Fig. 4A and B). Both zinc metalloproteinases share
the zincin motif (HExxH) with the five-stranded β-sheet of the
thermolysin-like peptidase (TLP) fold and present the canonical
non-prime site substrate-recognition motif, the edge strand.
Whereas clostridial collagenases belong to the gluzincin clan
employing a glutamate as the third proteinaceous zinc ligand,
MMPs are metzincins with a histidine as the third zinc ligand,
and a conserved methionine containing 1,4-β-turn (Met-turn)
forming the hydrophobic basement to the catalytic zinc [69,70].
In clostridial collagenases the structurally equivalent position is
taken by a conserved alanine positioned on the so called
glutamate helix [41,69]. Another noteworthy difference position
of the third zinc ligand: In MMPs the third zinc ligand is located
just 6 amino acids after the central HExxH motif, whereas
clostridial collagenases containa stretch of up to 30 amino acids
long that not only shapes the active site cleft, but also builds the
recently discovered calcium binding site crucial for enzymatic
activity [41].
In a second stepwe performed peptide docking experiments
using hexapeptide sequences. For collagenase G we used the
sequence Gly-Pro-Pro-Gly(S1′)-Pro-Ala (Fig. 4C), as identified by
our PICS analysis, which also resembles the prime site of
the classical substrate for clostridial collagenase, FALGPA. For
MMP1 we used the sequence Pro-Leu-Gly-Leu(S1′)-Ala-Gly
(Fig. 4D), mimicking the general MMP substrate (QF-24; [71]).
Most striking is their difference in the substrate recognition site
S1′. MMPs contain a well-defined hydrophobic pocket within
the lower catalytic subdomain, typically accommodating
leucine or isoleucine at P1′ (Fig. 4F), resembling a critical
determinant for substrate binding [72]. In contrast, clostridial
collagenases possess a double Gly motif preceding the edge
strand of the upper subdomain, forming a secondary oxyanionments of 108 cleavage sites for the peptidase domain of ColG
T are summarized as heat maps showing their relative
ndance of amino acids (middle panels), and as iceLogos [57]
ndance (right panels). Heat maps were created using Gnuplo
tted is on the y axes. P and P′ subsite positions are shown on
ds are shown above the axis, under-represented residues
e depicted in pink. For easier comparison, the same scalest
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carbonyl oxygen of a preferably small P1′ residue (Fig. 4E),
such as glycine or alanine, to the top of the active site.Notably, small amino acids are typically found at position P1
in MMP substrates [72]. In consequence, the subsites S2′ and
S3′ in clostridial collagenases are horizontally mirrored
Fig. 4 – In-silico comparison of collagenase G (left) and human MMP1 (right). (A, B) Ribbon representation of the unliganded
active site clefts. Key active site elements, such as the HExxH motif presenting central helix, edge strand, and hydrophobic
basement are depicted. The active site zinc, tetrahedrally coordinated by three proteinaceous residues (ball and stick
representation) and a water molecule (blue sphere) is shown in yellow. (C, D) Schematic representation of the hexapeptides
used for active site docking. Left: Gly-Pro-Pro-Gly(P1′)-Pro-Ala, used for MMP1; right: Pro-Leu-Gly-Leu(P1′)-Ala-Gly, used for
collagenase G. The corresponding substrate binding pockets are indicated. (E, F) Surface representation of the P3 to P3′ liganded
active site clefts. Prominent hydrophobic bulges and the S1′ pocket of MMP1 shape the active site clefts.
110 J O U R N A L O F P R O T E O M I C S 1 0 0 ( 2 0 1 4 ) 1 0 2 – 1 1 4compared to MMPs; subsite S2′ is provided by the lower
catalytic subdomain, and S3′ by the upper. In addition, in the
surface representation of our peptide docking result for
collagenase G, two prominent bulges built up by a big
aliphatic residue of the edge strand (Leu495) and an aromatic
residue of the wall forming motif (Phe515), respectively,
represent crucial determinants for subsites S1 and S2′,
typically occupied by proline.4. Discussion
In this study we demonstrate that the collagen specificity
of clostridial collagenases is imprinted within the active
site to an unusually high degree by matching active site
subsites precisely with the commonly cleaved collagen
Gly-Pro-X triplet motif. The unique and exquisite selectivity for
these triplets likely explains the high kcat/kM of clostridialcollagenases for native collagen that augments collagen exosite
binding by the collagen recruitment domain or the activator
domain. Thus, the cleavage specificity profiles for the peptidase
domains of the three different clostridial collagenases, namely of
collagenases G andH from C. histolyticum, and ColT from C. tetani,
showed a clear preferences for Pro in P2 and P2′, and Gly
dominating in P3 and P1′.
Recent research has revealed the complex mechanism of
clostridial collagenolysis on a molecular level and highlighted
the different levels of action involved [7,27,36–38,41,73–78]: In
a first step, C-terminally located collagen binding domains
(CBDs) of clostridial collagenases recognize the triple-helical
conformation of collagen, thus allowing binding and locali-
zation. In the second step, collagen fibers are swollen and
disintegrated by cooperative action of up to two PKDs together
with the CBDs, thereby exposing microfibrils and collagen
monomers. Microfibrils up to 40 Å in diameter are clamped by
the collagenase unit, mechanically expelling and unwinding
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and digest” mechanism. One strand after the other is then
aligned along the edge strand in the active site cleft of the
peptidase domain and cleaved at the scissile bond, between
hydroxyproline/proline (P1) and glycine (P1′). Subsequently
these are further degraded to oligopeptides due to the
additional tripeptidyl-carboxypeptidase activity of clostridial
collagenases. In contrast, mammalian collagenolytic MMPs
cleave collagen only at a single site between glycine (P1) and
leucine/isoleucine (P1′), that is located in a temporarily
unfolded, hypersensitive region of reduced hydroxyproline
content, and otherwise buried in the heart of the collagen
super helix [12,79,80]. Notably, unlike clostridial collagenases
targeting the bond lying on the amino side of the glycine,
MMPs target the bond nearest to the center of the triple helix
which is more difficult to access and hydrolyze. This is
reflected by particularly slow cleavage kinetics, such as kcat/km
of just 66 μM−1 h−1 for type I collagen and human MMP1 [81,82].
Thequestionofwhynature selected amoredifficult site to cleave
when a structurallymore accessible bond is nearby cannot be
empirically determined. We speculate that the importance
of maintaining structural tissue integrity by preventing
unwarranted extracellular cleavage of collagen outweighs
the need for a high rate of cleavage. Extracellular cleavage of
proteins is inherently under less cellular control than for
intracellular or phagocytosed substrates. Thus, a slower rate
of cleavage imparts a greater degree of control inmaintaining
fibril strength, despite active remodeling.
In our present study, we focused on the substrate specificity
of the peptidase domains of the clostridial collagenases G, H,
and T, as the activator domain and the collagen recruitment
domains were previously shown to be dispensable for
peptidolytic activity [36,40]. Further, exclusion of the collagen
binding and activator domains served to minimize unexpected
and undesirable exosite effects, such as broadening substrate
specificity by providing additional contact areas. Strikingly, our
analysis revealed eye-catching collagen-like specificity patterns
harbored within the peptidase domain, with Gly dominating
P3 and P1′, and Pro dominating P2 and P2′. A slightly looser
specificity was observed at positions P1, typically occupied
by hydroxyproline in collagen, with enrichment for large
bulky amino acids such as phenylalanine, tyrosine and
tryptophan next to the dominating proline. Bearing in mind
the complexity of the prerequisites needing to be fulfilled before
a single collagen strand becomes accessible for cleavage
[13,36,80], this high sequence specificity for the typical collagen
motifs Gly-Pro-X and Gly-X-Hyp is striking and reveals for the
first time that the high selectivity for native collagen is
specifically harbored within the peptidase domain of clostridial
collagenases. This adaption to substrates utilizing side by side
proline rigidity and glycine flexibility can be explained by the
active site structure. The edge strand guided the non-prime
substrate recognition sites S3 to S1 to formawide cleft, allowing
for residues such as Pro and Hyp that are not capable of
adopting an ideal extended beta-strand conformation due to
the cyclic nature of the side chains and thereby caused reduced
backbone flexibility [36,83,84]. A prominent bulge in S1 induces
a kink in the substrate upon binding, which can be perfectly
adapted by proline and hydroxyproline even though their steric
limitations. This rigidity, which also restricts the backboneconformation of neighboring residues [85], is relaxed by the
flexibility of Gly in P1′, which itself is fixed by the secondary S1′
oxyanion pocket, leading to substrate binding in a highly
distorted conformation around the scissile bond needed for
efficient hydrolysis [36,41]. Thus we conclude, that the
combination of the secondary oxyanion pocket in S1′ and the
hydrophobic bulge in S1 are in combination the primary active
site determinants of substrate recognition, imprinting the tight
specificity for collagen-like peptides in clostridial collagenases.
The differences between clostridial collagenases and mam-
malian MMP mechanisms of action are striking, but reflect the
different in vivo roles of these proteases. Whereas clostridial
collagenases are designed specifically to cleave and degrade
collagens, MMPs regulate a variety of processes by precise
proteolytic processing of many target proteins and so regulate
cell migration, proliferation, adhesion and signaling, but not so
much throughmatrix degradation rather throughmodulation of
extracellular signaling networks [86]. Deregulation of these
processes can result in pathological conditions e.g. cancer or
fibrotic diseases such as liver and lung fibrosis, or Morbus
Dupuytren [87–89]. Noteworthy, for the latter disease, clostridial
collagenase injections were recently approved as therapeutics to
breakdown the tough fibrous cords [29,90]. Contrary to the tightly
regulated endogenous host processes, clostridia secrete colla-
genases to rapidly degrade collagen in a fast, highly processive
and unrestrictedmanner, by cleaving collagens atmultiple sites.
This allows clostridia not only to utilize collagen as additional
carbon resourcebut also to assistshost invasionand colonization
during anaerobic infection by tissue degradation.
Our study supports other recent reports highlighting the
suitability of PICS for assaying protease specificity [56,91,92].
By appropriately choosing proteome sources and the digestion
enzyme during the peptide library generation step, specificity
of all protease classes can be determined in an unbiased and
cost efficient manner. Despite the unique and exquisite
cleavage site specificity of clostridial collagenases which
restricts the number of peptides that can be cleaved and
identified, PICS identified more than 100 unique cleavage
sites for each of the peptidase domains, thus yielding robust
sequence specificity logos.
Taken together, our active site specificity profiling of
clostridial collagenases revealed their substrate specificity to be
not only encoded by the collagen recruitment domains but also
within the active site of the peptidase domains, indicating the
molecular adaptation of these proteases to their peculiar
substrate on several levels. Furthermore, our results point
towards clostridial collagenases as dedicated extracellularmatrix
degraders, whether it is for decomposition of biomaterials or as
virulence factors in pathogenesis, and towards a co-evolution of
clostridial collagenases with their substrate, collagens.5. Conclusion
WeusedPICSand tandemmass spectrometry todefine theprime
and non-prime cleavage site specificities of the clostridial
collagenases ColG and ColH from C. histolyticum, and ColT from
C. tetani. Our results highlight the dedication of the peptidase
domains to collagen-related peptides as substrates and represent
an important piece in the complex puzzle of collagenolysis.
112 J O U R N A L O F P R O T E O M I C S 1 0 0 ( 2 0 1 4 ) 1 0 2 – 1 1 4Together with previous and ongoing structural biology efforts,
our findings pave the way for the rational development of better
peptidic substrates and inhibitors, and guide the engineering of
collagenase variants specific to the needs of the respective
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